Jump to main content.


1,3-Dichloropropene Quickview (CASRN 542-75-6)

Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.

Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.

For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.

Status of Data for 1,3-Dichloropropene

File First On-Line: 09/30/1987; Last Significant Revision: 05/25/2000

Category (section)
Status
Last Revised
Oral RfD Assessment On-line 05/25/2000
Inhalation RfC Assessment On-line 05/25/2000
Carcinogenicity Assessment On-line 05/25/2000
Synonyms
  • 542-75-6
  • 3-Chloroallyl chloride
  • alpha-Chloroallyl chloride
  • gamma-Chloroallyl chloride
  • 3-Chloropropenyl chloride
  • DCP
  • Dichloropropene
  • 1,3-Dichloropropene-1
  • 1,3-Dichloropropene
  • 1,3-Dichloro-2-propene
  • Dichloropropene, 1,3-
  • more...
1,3-Dichloropropene Source Documents
Revision History
Date Section Description
05/25/2000 II.A. Added oral cancer potency
Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect
Point of Departure*
UF RfD
Chronic irritation BMDL10 : 3.4 mg/kg-day 100 3 x10-2 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

Top of page


Reference Concentration for Chronic Inhalation Exposure (RfC)

Critical Effect
Point of Departure*
UF RfC
Hypertrophy/ hyperplasia of the nasal respiratory epithelium BMCL10 (HEC): 7.2 x10-1 mg/m3 30 2x10-2 mg/m3

* The Point of Departure listed serves as a basis from which the Inhalation RfC was derived. See Discussion of Conversion Factors and Assumptions for more details.

Top of page

Carcinogenicity Assessment for Lifetime Exposure
  • Weight-of-Evidence Characterization
    • B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals)
    • Known/likely human carcinogen
  • Weight-of-Evidence Narrative:
    • Although the available human data are inadequate, 1,3-dichloropropene is characterized as "likely" to be a human carcinogen in accordance with the Proposed Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1996).
    • This may be a synopsis of the full weight-of-evidence narrative. See IRIS Summary.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure

Oral Slope Factor(s)
Extrapolation Method
5 x10-2 per mg/kg-day 1
(Stott et al., 1995; liver tumors)
Linearized multistage model, extra risk
1 x10-1 per mg/kg-day 1
(NTP, 1985; urinary bladder tumors - recommended, see Full IRIS Summary)
Linearized multistage model, extra risk

1 This represents the lowest/highest of multiple discrete oral slope factors for this substance. See IRIS Summary.

Drinking Water Unit Risks
1 x10-6 per µg/L 2
(Stott et al., 1995; liver tumors)
3 x10-6 per µg/L 2
(NTP, 1985; urinary bladder tumors - recommended, see Full IRIS Summary)

2 This represents the lowest/highest of drinking water unit risks for this substance. See IRIS Summary.

Risk Level
Concentration
E-4 (1 in 10,000) 4x101 µg/L(NTP, 1985; urinary bladder tumors - recommended, see Full IRIS Summary)
E-5 (1 in 100,000) 4 µg/L(NTP, 1985; urinary bladder tumors - recommended, see Full IRIS Summary)
E-6 (1 in 1,000,000) 4x10-1 µg/L(NTP, 1985; urinary bladder tumors - recommended, see Full IRIS Summary)
 
E-4 (1 in 10,000) 7x101 µg/L(NTP, 1985; liver tumors)
E-5 (1 in 100,000) 7 µg/L(NTP, 1985; liver tumors)
E-6 (1 in 1,000,000) 7x10-1 µg/L(NTP, 1985; liver tumors)
 
E-4 (1 in 10,000) 8x101 µg/L(Stott et al., 1995; liver tumors)
E-5 (1 in 100,000) 8 µg/L(Stott et al., 1995; liver tumors)
E-6 (1 in 1,000,000) 8x10-1 µg/L(Stott et al., 1995; liver tumors)
  • Dose-Response Data (Carcinogenicity, Oral Exposure)
    • Tumor Type: Urinary bladder carcinoma (NTP, 1985); hepatocellular adenoma/ carcinoma (NTP, 1985; Stott et al., 1995)
    • Test Species: Female mouse (NTP, 1985); male rat (NTP, 1985; Stott et al., 1995)
    • Route: Oral, gavage (NTP, 1985); dietary (Stott et al., 1995)
    • Reference: NTP, 1985; Stott et al., 1995

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure

Inhalation Unit Risk(s)
Extrapolation Method
4 x10-6 per µg/m3 Linearized multistage model, extra risk

Inhalation Concentrations at Specified Risk Levels

Risk Level
Concentration
E-4 (1 in 10,000) 2x101 µg/m3
E-5 (1 in 100,000) 2 µg/m3
E-6 (1 in 1,000,000) 2x10-1 µg/m3

Top of page


Recent Additions | Advanced Search | IRIS Home | Environmental Assessment | Research


Local Navigation


Jump to main content.